Mostrar el registro sencillo del ítem

dc.contributor.authorCerdó, Tomáses_ES
dc.contributor.authorRuiz, Aliciaes_ES
dc.contributor.authorSuárez, Antonioes_ES
dc.contributor.authorCampoy Folgoso, Aliciaes_ES
dc.date.accessioned2017-12-22T12:16:27Z
dc.date.available2017-12-22T12:16:27Z
dc.date.issued2017-11-14
dc.identifier.citationCerdó, T.; et al. Probiotic, Prebiotic, and Brain Development. Nutrients, 9(11): 1247 (2017). [http://hdl.handle.net/10481/48676]es_ES
dc.identifier.issn2072-6643
dc.identifier.urihttp://hdl.handle.net/10481/48676
dc.description.abstractRecently, a number of studies have demonstrated the existence of a link between the emotional and cognitive centres of the brain and peripheral functions through the bi-directional interaction between the central nervous system and the enteric nervous system. Therefore, the use of bacteria as therapeutics has attracted much interest. Recent research has found that there are a variety of mechanisms by which bacteria can signal to the brain and influence several processes in relation to neurotransmission, neurogenesis, and behaviour. Data derived from both in vitro experiments and in vivo clinical trials have supported some of these new health implications. While recent molecular advancement has provided strong indications to support and justify the role of the gut microbiota on the gut–brain axis, it is still not clear whether manipulations through probiotics and prebiotics administration could be beneficial in the treatment of neurological problems. The understanding of the gut microbiota and its activities is essential for the generation of future personalized healthcare strategies. Here, we explore and summarize the potential beneficial effects of probiotics and prebiotics in the neurodevelopmental process and in the prevention and treatment of certain neurological human diseases, highlighting current and future perspectives in this topic.en_EN
dc.description.sponsorshipThis work was supported by the European Union’s 7th Framework Programme under grant agreement No. 613979 (MyNewGut Project 2013/KB/613979)en_EN
dc.description.sponsorshipSpanish Ministry of Economy and Competitiveness (MINECO) BFU2012-40254-C03-01.en
dc.description.sponsorshipTomás Cerdó participated in the Ph.D. Program in Biomedicine of the University of Granada and is a fellow of the FPI (BES-2013-065133) program at the Spanish Ministry of Economy and Competitiveness.en
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.relationinfo:eu-repo/grantAgreement/EC/H2020/613979es_ES
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivs 3.0 Licensees_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es_ES
dc.subjectMicrobiotaen_EN
dc.subjectPrebioticsen_EN
dc.subjectProbioticsen_EN
dc.subjectHealth en_EN
dc.subjectDiseaseen_EN
dc.titleProbiotic, Prebiotic, and Brain Developmenten_EN
dc.typejournal articleen_EN
dc.rights.accessRightsopen accessen_EN
dc.identifier.doi10.3390/nu9111247


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License
Excepto si se señala otra cosa, la licencia del ítem se describe como Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License